Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $9.02 Million - $14.5 Million
-1,288,000 Reduced 38.75%
2,036,000 $14.3 Million
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $1.43 Million - $1.78 Million
188,000 Added 5.99%
3,324,000 $28.3 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $23.3 Million - $46.4 Million
2,636,000 Added 527.2%
3,136,000 $28.7 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $5.44 Million - $10 Million
500,000 New
500,000 $5.71 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.